Omzo Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: Clinician-guided compounded GLP-1 with free delivery and FSA/HSA
Omzo scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Omzo is a multi-pillar telehealth service (weight loss, women's hormone health, sexual health, hair, skin, daily health) offering clinician-guided compounded GLP-1 — semaglutide and tirzepatide — with free discreet delivery and FSA/HSA eligibility. Medications are filled by an independent state-licensed compounding pharmacy. Pricing is not published on the marketing site (it appears after the intake quiz), and the company does not name its legal entity, pharmacy partner, or state-availability list.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Omzo
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Omzo at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Omzo
Each dimension is scored algorithmically from Omzo’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.5/10At $179/mo, Omzo runs about 6% above the $170 median for GLP-1 providers.
Effectiveness25%
7.8/10Omzo offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10Omzo's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.6/10Omzo provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Omzo review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Omzo
We walked Omzo’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Share goals, health history, and lifestyle through a personalized questionnaire (Weight Quiz).
- 2Licensed clinicians review your information and create a tailored weight-loss plan.
- 3If prescribed, GLP-1 medication is shipped in discreet packaging.
- 4Track progress, adjust dosage, and message the care team through the Omzo app.
- Offers compounded Semaglutide and Tirzepatide (Ozempic listed as limited stock; Zepbound vials 'coming soon').
- No monthly price is shown on the weight-loss page; pricing surfaces after the quiz.
- Explicitly states compounded drugs are not FDA-approved and not evaluated by the FDA.
- Marketed as FSA & HSA eligible with free discreet delivery.
- Omzo states it is not a medical practice or pharmacy; clinicians are third-party licensed networks.
GLP-1 medications Omzo offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Omzo's current pricing and active discounts before you decide.
What we like
- Compounded GLP-1 (semaglutide and tirzepatide) with clinician guidance
- Free, discreet delivery on all treatments
- FSA/HSA eligible
- Multi-pillar: also women's hormone, sexual health, hair, skin, and daily health
Watch-outs
- Pricing not published on the site — shown only after the intake quiz
- Compounding pharmacy partner not named (states only 'independent state-licensed')
- States of operation not published
- Not LegitScript-certified (no certification displayed)
- Legal entity not named; governing law given only as 'the state in which Omzo operates'
Is Omzo worth it? Our verdict
Omzo positions itself around one thing: Clinician-guided compounded GLP-1 with free delivery and FSA/HSA. It runs $179/month.
Where Omzo tries to set itself apart is the extras: GLP-1 weight loss, Free delivery, and FSA/HSA eligible.
How much Omzo actually costs
- semaglutide — $179/month
- tirzepatide — $279/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
For a direct comparison, DudeMeds runs semaglutide and tirzepatide from $175/month — worth pricing against Omzo before you commit.
Medications: what Omzo prescribes
Omzo prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes.
Who Omzo is best for — and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
Omzo is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Bodybuilding Health+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Omzo scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Omzo?
Starting at $179/month. See current pricing and start your free consultation.
Omzo might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Omzo review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Omzo's current pricing
Plans start at $179/month. Start your free consultation to check eligibility and today's price.